Share

September 11, 2012; 79 (11) Clinical/Scientific Notes

Oculomotor and visual axis systems sparing in spinocerebellar ataxia type 13R420H

Michael F. Waters, Sankarasubramoney H. Subramony, Joel Advincula, Susan Perlman, Tetsuo Ashizawa
First published August 29, 2012, DOI: https://doi.org/10.1212/WNL.0b013e3182698d5c
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
90

Share

Article Information

vol. 79 no. 11 1181-1182
DOI: 
https://doi.org/10.1212/WNL.0b013e3182698d5c
PubMed: 
22933745
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received January 20, 2012
  • Accepted April 6, 2012
  • First Published August 29, 2012.

Article Versions

Copyright & Usage: 
Copyright © 2012 by AAN Enterprises, Inc.

Author Disclosures

    1. Michael F. Waters, MD, PhD,
    2. Sankarasubramoney H. Subramony, MD,
    3. Joel Advincula, MD,
    4. Susan Perlman, MD and
    5. Tetsuo Ashizawa, MD
  1. Michael F. Waters, MD, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH NINDS (NS054715-01A1) PI 12/07-12/12

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Sankarasubramoney H. Subramony, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Handbook of Clinical Neurology, volume editor, 2011 Speakers’ Bureaus: Athena Diagnostics

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. 2009-2011:Clinical Research Consortium for Spinocerebellar Ataxias (Co-investigator. T Ashizawa M.D. PI). NINDS

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 2010-2011Clinical outcome measures in Friedreich Ataxia (Friedreich Ataxia Research Alliance): Site principal investigator 2009-2012New Initiatives in Ataxia Research. National Ataxia Foundation (Principal Investigator)

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Joel Advincula, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Susan Perlman, MD and
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Edison Pharmaceuticals for a compassionate drug trial in one patient. Company provided funding for lab work required in study.

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. National Ataxia Foundation for maintenance of the web- based database being used in a different study.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Tetsuo Ashizawa, MD
    6. Scientific Advisory Boards:

    1. Myotonic Dystrophy Foundation 2011, 2012; NIH 2011, 2012; National Ataxia Foundation 2011, 2012

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Editorial Boards:; PLoS ONE: Associate Editor, 2011, 2012

    Patents:

    1. DNA test for SCA10, US Patent 6855497 [Issued February 15, 2005]; PVA or PEG conjugates of peptides for epitope specific immunosuppression, US Patent 6048529 [Issued April 11, 2000]; METHODS AND COMPOSITIONS INVOLVING NUCLEOTIDE REPEAT DISORDERS, Pub. No.: WO/2007/121272 [Publication Date October 25, …

  1. From the Departments of Neurology (M.F.W., S.H.S., T.A.) and Neuroscience (M.F.W.), University of Florida College of Medicine, Gainesville; Western Visayas State University Medical Center (J.A.), Iloilo City, Philippines; and Department of Neurology (S.P.), UCLA Medical Center, Los Angeles, CA.
  1. Correspondence & reprint requests to Dr. Waters: mwaters{at}neurology.ufl.edu
View Full Text

Article usage

Article usage: August 2012 to May 2023

AbstractFullPdfSource
Aug 20121501Highwire
Sep 20123892525Highwire
Oct 201224104Highwire
Nov 2012091Highwire
Dec 2012081Highwire
Jan 2013074Highwire
Feb 20130110Highwire
Mar 2013070Highwire
Apr 2013091Highwire
May 2013082Highwire
Jun 20131440Highwire
Jul 2013500Highwire
Aug 2013200Highwire
Sep 2013400Highwire
Oct 2013993Highwire
Nov 2013523Highwire
Dec 2013221Highwire
Jan 2014300Highwire
Feb 2014630Highwire
Mar 2014620Highwire
Apr 20141030Highwire
May 2014251Highwire
Jun 2014530Highwire
Jul 2014461Highwire
Aug 2014400Highwire
Sep 2014600Highwire
Oct 2014600Highwire
Nov 2014410Highwire
Dec 2014600Highwire
Jan 2015600Highwire
Jan 2015020pmc
Feb 2015900Highwire
Feb 2015040pmc
Mar 20151000Highwire
Apr 2015500Highwire
May 2015500Highwire
May 2015020pmc
Jun 20151100Highwire
Jun 2015041pmc
Jul 20151101Highwire
Jul 2015021pmc
Aug 2015600Highwire
Aug 2015030pmc
Sep 20151100Highwire
Sep 2015050pmc
Oct 2015800Highwire
Oct 2015010pmc
Nov 2015500Highwire
Nov 2015033pmc
Dec 20151000Highwire
Dec 2015010pmc
Jan 2016400Highwire
Jan 2016021pmc
Feb 2016800Highwire
Feb 2016021pmc
Mar 2016300Highwire
Mar 2016010pmc
Apr 2016010Highwire
Apr 2016010pmc
May 20161100Highwire
May 2016023pmc
Jun 2016400Highwire
Jun 2016012pmc
Jul 20161100Highwire
Jul 2016010pmc
Aug 20161501Highwire
Sep 20161200Highwire
Sep 2016020pmc
Oct 20161200Highwire
Nov 20162011Highwire
Dec 20161100Highwire
Dec 2016020pmc
Jan 2017800Highwire
Jan 2017011pmc
Feb 2017801Highwire
Feb 2017044pmc
Mar 2017700Highwire
Mar 2017021pmc
Apr 2017900Highwire
May 2017900Highwire
May 2017210pmc
Jun 2017600Highwire
Jun 2017011pmc
Jul 2017200Highwire
Jul 2017022pmc
Aug 2017300Highwire
Aug 2017011pmc
Sep 2017500Highwire
Sep 2017121pmc
Oct 2017210Highwire
Oct 2017233pmc
Nov 2017100Highwire
Dec 20171500Highwire
Jan 2018700Highwire
Feb 2018300Highwire
Mar 2018200Highwire
Apr 2018300Highwire
Apr 2018123pmc
May 20181201Highwire
Jun 2018600Highwire
Jun 2018111pmc
Jul 2018200Highwire
Aug 2018300Highwire
Sep 2018200Highwire
Oct 2018400Highwire
Nov 2018700Highwire
Dec 2018800Highwire
Jan 2019100Highwire
Feb 2019600Highwire
Mar 2019200Highwire
Apr 2019301Highwire
May 20191100Highwire
Jun 2019800Highwire
Jul 2019100Highwire
Aug 2019600Highwire
Sep 2019100Highwire
Oct 2019500Highwire
Nov 2019500Highwire
Dec 2019800Highwire
Jan 2020401Highwire
Feb 2020200Highwire
Mar 20201900Highwire
Apr 2020501Highwire
May 2020100Highwire
Jun 2020400Highwire
Jul 2020900Highwire
Aug 2020800Highwire
Sep 2020100Highwire
Oct 2020600Highwire
Nov 2020610Highwire
Dec 2020300Highwire
Jan 2021100Highwire
Feb 2021400Highwire
Mar 2021900Highwire
Apr 2021300Highwire
May 2021800Highwire
Jun 2021900Highwire
Jul 2021700Highwire
Aug 2021600Highwire
Sep 2021200Highwire
Oct 20211100Highwire
Nov 20211503Highwire
Dec 2021700Highwire
Jan 2022300Highwire
Feb 20221500Highwire
Mar 20221700Highwire
Apr 2022800Highwire
May 20221100Highwire
Jun 20221200Highwire
Jul 2022801Highwire
Aug 2022600Highwire
Sep 20221200Highwire
Oct 2022400Highwire
Nov 20221200Highwire
Dec 2022500Highwire
Jan 2023900Highwire
Feb 2023800Highwire
Mar 20231510Highwire
Apr 2023400Highwire
May 2023700Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles